药物诱导的视网膜静脉封闭:来自FDA不良事件报告系统的不成比例分析 (2004-2023)

Xiao-Dong Chen1,2,3, Kun-Hong Xiao3, Chao-Bing Zhou1,4

  • 1Department of Ophthalmology, Hui'an County Hospital, Quanzhou, Fujian, China.

Frontiers in pharmacology
|December 30, 2024
PubMed
概括

这项研究分析了FDA的数据,以找到与视网膜静脉封闭 (RVO) 相关的药物. 米拉贝格隆,拉洛西芬和塔达拉菲尔是具有RVO风险信号最高的药物之一.

相关概念视频

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
730
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.8K